Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 77 pembrolizumab 59 Carboplatin 57 Bevacizumab 57 Specimen Handling 48 Magnetic Resonance Spectroscopy 39 Cisplatin 32 olaparib 31 Gemcitabine 25 liposomal doxorubicin 24 Biopsy 20 Taxes 19 Topotecan 17 Nivolumab 17 Cyclophosphamide 16 Immunoglobulin G 15 Doxorubicin 15 Disulfides 15 niraparib 12 fludarabine 12 Surveys and Questionnaires 12 Letrozole 12 lenvatinib 11 durvalumab 11 atezolizumab 11 Fulvestrant 10 Drug Therapy 10 abemaciclib 9 Docetaxel 9 Brachytherapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

senaparib × Gynecologic × 90 days × Clear all

NCT07586449 2026-05-14

RESO

Zhejiang Cancer Hospital

Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡